- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VIR
Recent news which mentions VIR
From Benzinga
From MarketWatch
5 Value Stocks In The Healthcare Sector
April 25, 2022
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
3 Pharmaceutical Stocks With Awesome Futures
April 09, 2022
From Motley Fool
From Benzinga
How to Find New Stocks for Your Portfolio
April 06, 2022
From Motley Fool
Why Shares of Vir Biotechnology Rose 20.4% This Week
April 01, 2022
From Motley Fool
51 Biggest Movers From Yesterday
March 31, 2022
From Benzinga
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher
March 30, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 30, 2022
From Benzinga
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
March 30, 2022
From Benzinga
From Benzinga
These 2 Nasdaq Biotech Stocks Are Soaring Wednesday Morning
March 30, 2022
From Motley Fool
24 Stocks Moving in Wednesday's Pre-Market Session
March 30, 2022
From Benzinga
From InvestorPlace
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 28, 2022
From Benzinga
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
From Benzinga
64 Biggest Movers From Friday
March 28, 2022
From Benzinga
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022
March 25, 2022
From Motley Fool
From Benzinga
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows
March 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 07, 2022
From Benzinga
From Motley Fool
From Benzinga
Where to Invest $10,000 in a Bear Market
March 02, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.